The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 33, No. 11, pp. 1167-1172. DOI 10.1345/aph.18460
© 1999 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pickard, A.
Right arrow Articles by Farris, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pickard, A.
Right arrow Articles by Farris, K.


Research Articles

The impact of pharmacist interventions on health-related quality of life

AS Pickard, JA Johnson, and KB Farris

OBJECTIVE: To describe and evaluate pharmacy practice-based studies that include health-related quality of life (HRQL) as an outcome measure in assessments of pharmacist interventions and to recommend approaches for incorporating HRQL as a patient outcome in pharmacy practice-based intervention studies. METHODS: Citations were identified in MEDLINE, Healthstar, EMBASE, and International Pharmaceutical Abstracts from January 1988 to February 1999 using terms for health-related quality of life and pharmacist interventions. Abstracts were screened by two reviewers and articles that reported a pharmacist intervention performed with HRQL as an outcome measure were included. RESULTS: Of 689 citations identified by the literature search terms, 11 met the inclusion criteria. Nine studies contained a disease-specific focus. The SF-36, or its variations, was the only generic instrument used, and seven studies described using a disease-specific instrument. Pharmacist interventions inconsistently demonstrated positive effects on patient HRQL. DISCUSSION: Possible reasons for not detecting significant differences in HRQL include length of study period, insufficient sample size and power, selection bias, labeling effects, the type of measure applied, and lack of actual influence of pharmaceutical services on HRQL. Strategies to strengthen the design and methodologic approach, such as the reporting of effect size, are recommended. CONCLUSIONS: In order to demonstrate the positive effect of pharmaceutical services on patient health, pharmacy practice researchers should continue incorporating HRQL outcome measures, complemented by clinical, economic, and other humanistic outcome indicators.


This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
L. G. Planas
Intervention design, implementation, and evaluation
Am. J. Health Syst. Pharm., October 1, 2008; 65(19): 1854 - 1863.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
A S. Pickard and S.-Y. Hung
An Update on Evidence of Clinical Pharmacy Services' Impact on Health-Related Quality of Life
Ann. Pharmacother., September 1, 2006; 40(9): 1623 - 1634.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. J. Kaboli, A. B. Hoth, B. J. McClimon, and J. L. Schnipper
Clinical pharmacists and inpatient medical care: a systematic review.
Arch Intern Med, May 8, 2006; 166(9): 955 - 964.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1999 by Harvey Whitney Books Company.